Choreo LLC’s Repligen RGEN Stock Holding History

Choreo LLC’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,574	Closed	-$375K	–	1711
2024 Q3	$375K	Buy	+2,574	New	+$369K	0.01%	1072

Other funds holding RGEN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Choreo LLC's RGEN Position: Q4 2024 in Review

Choreo LLC sold out of Repligen (RGEN) in Q4 2024, closing a stake of 2,574 shares — an estimated $375K sold.

Choreo LLC first reported a position in RGEN in Q3 2024 and held it in 1 quarter. The position peaked at $375K in Q3 2024. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.

Choreo LLC reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
Choreo LLC sold 2,574 Repligen shares in Q4 2024, an estimated $375K.
Choreo LLC first reported a position in Repligen in Q3 2024 and held it in 1 quarter.
Choreo LLC's Repligen position peaked at $375K in Q3 2024.
431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.

Based on Choreo LLC's 13F filing for Q4 2024, filed 27 Jan 2025.